EVG: Sit files 13D, discloses 6.4% stake, 857,119 shares
Sit Investment Associates and Sit Fixed Income Advisors filed a Schedule 13D reporting a stake in Eaton Vance Short Duration Diversified Income Fund (EVG).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sit Investment Associates and Sit Fixed Income Advisors filed a Schedule 13D reporting a stake in Eaton Vance Short Duration Diversified Income Fund (EVG). They beneficially own 857,119 shares, representing 6.4% of the fund’s outstanding common stock.
The percentage is based on 13,452,867 shares outstanding as of April 30, 2025. The Sit entities report shared voting and dispositive power over 857,119 shares and no sole voting or dispositive power. The position is held in client accounts; no single client holds more than 5% of outstanding shares, and the firms’ directors or executive officers do not own shares directly.
The stake was acquired in open market purchases for investment purposes. The Sit entities may continue to buy, hold, vote, trade, or sell shares and may discuss performance, distributions, capitalization, investment strategy, and portfolio with management and the board. They also indicate they may make shareholder proposals or nominate directors.
Insights
13D shows a 6.4% EVG stake with possible engagement, no actions committed.
Sit Investment Associates and affiliate disclosed 857,119 shares of EVG, equal to 6.4% based on 13,452,867 shares outstanding as of April 30, 2025. They have shared voting and dispositive power, reflecting advisory control across client accounts rather than proprietary ownership.
The filing states investment intent but allows for engagement with management and the board, including potential shareholder proposals or director nominations. That language is typical for a 13D and signals optionality rather than a declared campaign.
Market impact, if any, depends on future steps by the holders. Subsequent disclosures may detail proposals or changes in position size.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake did Sit disclose in EVG on Schedule 13D?
Could Sit engage with EVG’s management or board?
Did any single Sit client exceed 5% ownership of EVG?
Who signed the Schedule 13D for the Sit entities?
AI-generated analysis. How Rhea-AI works. Not financial advice.